Compare AbCellera Biologics Inc (ABCL) vs GoPro Inc (GPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs GoPro Inc — how do they compare? AbCellera Biologics Inc trades at $8.97 (market cap $2.85B), while GoPro Inc trades at $0.62 (market cap $120.42M). The key difference: AbCellera Biologics Inc is far larger — about 23.7× GoPro Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | GPRO | |
|---|---|---|
Market Cap | $2.85B | $120.42M |
Sector | Health | Technology |
52-Week High | $9.76 | $2.88 |
52-Week Low | $2.78 | $0.62 |
Enterprise Value | $2.45B | $168.37M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →
